Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Health Insurance

Wednesday Links

Posted on July 13, 2022July 25, 2022 by John C. Goodman
  • How an economist thinks about abortion. Well, at least one economist.
  • Why is Google investing in health care?
  • Is developing Covid vaccines a profitable venture for drug companies? “The answer is a resounding ‘no’. In fact, in most cases, developing mRNA vaccines for a portfolio of emerging diseases would be a money loser.”
  • How common is prior authorization?
  • Price controls on insulin: The (intended?) result will that be that consumers will pay more, diabetes complications will get worse, and incumbent manufacturers will make more money.
  • Almost a quarter of Americans over the age of 18 are now medicated for one or more of these conditions.  (HT: Tyler)
  • Canada’s health care providers say their system is “collapsing.”
+

Drug Maker Applies to Sell The Pill Over the Counter without a Prescription

Posted on July 11, 2022July 11, 2022 by Devon Herrick

According to the New York Times the US Food and Drug Administration has received an application by a drug company to switch a prescription birth control pill to over-the-counter status. A Paris-based company, HRA Pharma asked the FDA to make its pill legal to sell without a prescription. That move is controversial, not just because of the recent Supreme Court ruling on Roe v Wade. Another pill manufacturer, Cadence Health, is also preparing to submit an application to switch its pill to OTC as well.

+

Monday Links

Posted on July 11, 2022July 25, 2022 by John C. Goodman
  • 7 Monkeypox questions answered. It doesn’t look good for sexually active gay men, and vaccine production is at a trickle.
  • California is going to make its own insulin.
  • Mini “Build Back Better” bill to cost $1 trillion. “It’s better than nothing,” said one progressive.
  • Study: giving people money doesn’t make them better off.  “The data are most consistent with the notion that receiving some but not enough money made participants’ needs—and the gap between their resources and needs—more salient, which in turn generated feelings of distress.”
  • Biden’s Executive Order on Abortion: “Nothing in his executive order will fundamentally change the everyday lives of poor women in a red state,” Georgetown University health law professor Lawrence Gostin told Vox.
  • David Henderson: Abortion in Canada is rationed by waiting.
+

Why Don’t People Trust the CDC?

Posted on July 3, 2022 by John C. Goodman

Consider the CDC studies on school mask mandates, which have uniformly claimed benefits. Two researchers at the University of Toronto and University of California, Davis recently sought to replicate a CDC study that found that pediatric Covid cases increased faster in U.S. counties that didn’t have school mask mandates compared with those that did….

As another example, recall the CDC’s widely cited studies last fall that purportedly found vaccines provide better protection than natural immunity from infection…. But a new study, published this month in the New England Journal of Medicine, finds that natural immunity provides more-durable and stronger protection than vaccines.

Allysia Finley in the WSJ

+
  • Previous
  • 1
  • …
  • 186
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • …
  • 195
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 40 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom